TranslateGordon Fox • November 22, 2022
The Holidays Can Be Healthy For Your Heart
We’ve all had the experience: holidays can mean eating too much (much of which isn’t good for you), drinking too much, and getting no exercise. It doesn’t have to be like that!
A new article in Cardiology Magazine (published by the American College of Cardiologists) suggests a strategy for heart-healthy holidays. There are strategies for modifying recipes to make them more healthy, scheduling your exercise to make sure you do it, and more. There are even a couple of recipes included. Give it a read !
P.S. Remember: gratitude is actually good for your heart!
The post The Holidays Can Be Healthy For Your Heart appeared first on Hypertrophic Cardiomyopathy Association.
HCMA Blog
Investigative journalists Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang from Pro Publica and NPR have concluded a 14-month long investigation into the quality of generic drugs coming into the United States from overseas. Among the many voices that spoke up for American patients was HCMA Founder and CEO, Lisa Salberg who has felt the effects of low-quality drugs personally. Salberg believes that fixing this problem is something we can do, even in this time, when even health care is highly politicized. Read the key takeaways from ProPublica’s 14-month investigation into the FDA’s oversight of foreign drugmakers in Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs .
Alnylam press release on the European Commission approval of AMVUTTRA® (vutrisiran) forwild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM) as an additional indication
AMVUTTRA® (vutrisiran) has been approved by the U.S. Food and Drug Administration (FDA) to treat ATTR-CM in adults.